Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127100) titled 'Analysis of the Current Situation of Diagnosis and Treatment of Inflammatory Breast Cancer in China, Exploration of New Therapies and Development of New Targets: A Special Disease Cohort Study' on June 24.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: The Fourth Hospital of Hebei Medical University

Condition: Breast cancer

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2024-10-23

Target Sample Size: Treatment group:400;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=313107

Published by HT Digital Cont...